ABRILADA
- Product NDC
- 50090-7998
- 11-digit product format
- 500907998
- Labeler code
- 50090
- Product ID
- 50090-7998_fa5fba33-fd55-4011-8871-2c2013b5a0e4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- adalimumab-afzb
- Dosage form
- KIT
- Labeler
- A-S Medication Solutions
- Application
- BLA761118
- Marketing category
- BLA
- Marketing start
- 2023-12-14
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ABRILADA | ADALIMUMAB-AFZB | A-S Medication Solutions | 79943fe6-1249-4074-9aed-c53937820d0f | 2026-06-18 | Boxed warning, Warnings, Adverse reactions | BLA761118 50090-7998 |
| ABRILADA | ADALIMUMAB-AFZB | Pfizer Laboratories Div Pfizer Inc | 5ef1c7cf-466f-495e-8d13-82e2ddfa7a4f | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | BLA761118 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ABRILADA
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 79943fe6-1249-4074-9aed-c53937820d0f | Available on FDA.report |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761118 | Abrilada | adalimumab-afzb | 351(k) Interchangeable | Rx | 2026-06-01 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Status |
|---|---|---|---|---|---|---|
| 50090-7998-0 | 50090799800 | 2 KIT in 1 CARTON (50090-7998-0) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) | 2 kit | 2026-06-17 | 0 | Current |